News - Pharmaceutical
Par Pharmaceutical Begins Shipment of Rizatriptan Benzoate Tablets and ...
2 January 2013
WOODCLIFF LAKE, N.J., Jan. 2, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has begun shipping 5 mg and 10 mg strengths of rizatriptan benzoate tablets and 5 mg and 10 ...
Click on the link to read the full article at PR Newswire (press release) (This link will open in a new window)Deloitte: Saudi Arabia pharmaceutical market forecast to reach $4.7bn by 2016
2 January 2013
Among specific market segments, pharmaceuticals accounted for $798bn in market revenue in 2011; and biotechnology accounted for $289bn. Saudi Arabia for example, one of the largest pharmaceutical markets in the Middle East region, is forecast to ...
Click on the link to read the full article at AME Info (This link will open in a new window)FILED FOR APPROVAL
2 January 2013
TAIPEI, Taiwan, Dec. 11, 2012 /PRNewswire/ -- Lotus Pharmaceutical Company Inc. has confirmed its submission of Abbreviated New Drug Application ("ANDA") for Orlistat capsules, a generic version of Xenical
Click on the link to read the full article at PharmaLive (press release) (subscription) (This link will open in a new window)West Pharmaceutical Services Moves Up In Market Cap Rank, Passing ...
1 January 2013
Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given company's stock. Many beginning ...
Click on the link to read the full article at Forbes (This link will open in a new window)KV PHARMACEUTICAL CO : K-V Pharmaceutical Receives Court Approval of ...
1 January 2013
St. Louis, MO, December 28, 2012 - K-V Pharmaceutical Company ("K-V" or "the Company") today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's ...
Click on the link to read the full article at 4-traders (This link will open in a new window)Pharma, Too Big To Jail: Medical Pharmaceutical Complex Exposed: click here
1 January 2013
These discussions are not moderated. We rely on users to police themselves, and flag inappropriate comments and behavior. In accordance with our Guidelines and Policies, we reserve the right to remove any post at any time for any reason, and will ...
Click on the link to read the full article at OpEdNews (This link will open in a new window)Pentagon Spending on Prescription Drugs Soars
31 December 2013
That was nearly double the growth rate of overall pharmaceutical sales in the United States during the same period. Prescriptions for active-duty troops account for only about 10 percent of those filled under Tricare. Instead, experts say, it's ...
Click on the link to read the full article at Pharmaceutical Processing (This link will open in a new window)Covidien expects better 2013 pharmaceutical sales
31 December 2013
Covidien now expects revenue for its Mallinckrodt pharmaceutical business to grow between 3 and 6 percent in 2013, up from a previous estimate of 1 to 4 percent. It said the change reflects good performance from the business and marketing approval for ...
Click on the link to read the full article at Businessweek (This link will open in a new window)"Colby Pharmaceutical Company - Product Pipeline Review - 2012" - New ...
31 December 2013
Boston, MA -- (SBWIRE) -- 12/31/2012 -- Global Market Direct's pharmaceuticals report, "Colby Pharmaceutical Company - Product Pipeline Review - 2012" provides data on the Colby Pharmaceutical Company's research and development focus. The report ...
Click on the link to read the full article at SBWire (press release) (This link will open in a new window)Peregrine Pharmaceutical (PPHM) Falls on $75M 'At Market' Stock Sale ...
31 December 2013
Peregrine Pharmaceutical (NASDAQ: PPHM) is lower early Monday after disclosing after the close Friday that on December 27, 2012, it entered into an At Market Issuance Sales Agreement, with MLV & Co. LLC under which the Company may issue and sell ...
Click on the link to read the full article at StreetInsider.com (subscription) (This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
